Athersys Inc ATHX:NASDAQ

Last Price$0.82NASDAQ Previous Close - Last Trade as of 3:57PM ET 1/26/22

Today's Change+0.005(0.60%)
Bid (Size)$0.76 (60)
Ask (Size)$0.93 (1)
Day Low / High$0.81 - 0.87
Volume1.2 M

Athersys Partner Completes Enrollment in Phase 2/3 Trial of MultiStem Cell Therapy for Ischemic Stroke; Shares Rise Midday

12:25PM ET 8/10/2021 MT Newswires
Athersys (ATHX) said Tuesday its partner Healios completed enrollment in its phase 2/3 trial in Japan evaluating the company's MultiStem cell therapy treatment in patients who have suffered an ischemic stroke.

"We believe that MultiStem has the potential to improve standard of care for patients that have suffered a stroke while also extending the treatment window, providing a potential treatment option for many more patients," said Athersys interim CEO William Lehmann, Jr. "We look forward to the topline results which Healios is targeting for release later this year."

Shares of Athersys were up nearly 6% in midday trading.

Price: 1.63, Change: +0.10, Percent Change: +6.21